Published by
@ShahidNShah
@ShahidNShah
April 20, 2023
Online
The complexity and rapid growth of autologous and allogeneic cell therapies presents significant new CMC challenges companies must address and overcome. Our experts share their personal experiences and insight to help anticipate challenges and implement better CMC strategies to accelerate success. Developing and engineering recombinant protein expression platforms are not for the faint of heart. Many variables must be considered during the development process. When cell line challenges arise, scientists must engineer solutions to overcome. In this interactive virtual event, our experts share their personal experiences and insight to help you identify and overcome today’s cell line challenges. Topics include cell therapy analytical challenges, identifying & overcoming cell therapy CMC challenges, flow cytometry assay development, and more.
Continue reading at industryevents.com
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 22, 2024 at 12:50pm